Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uberto Fumagalli

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Cancers|January 11, 2024
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric CancerMaria Bencivenga, Silvia Ministrini, Paolo Morgagni, et al.
Updates in Surgery|July 16, 2017
Complications after gastrectomy for cancer: Italian perspectiveGian Luca Baiocchi, Simone Giacopuzzi, Daniele Marrelli, et al.
Cancers|February 10, 2021
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective AnalysisStefano de Pascale, Paolo Parise, Michele Valmasoni, et al.
Cancers|October 23, 2021
The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction AdenocarcinomaRoberto Fiocca, Luca Mastracci, Marialuisa Lugaresi, et al.
Frontiers in Oncology|April 4, 2022
The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon's Conduct During the Surgical Treatment of Advanced Gastric Cancer-Study Protocol for an International Multicenter Prospective StudyPietro Maria Lombardi, Michele Mazzola, Vincenzo Nicastro, et al.
Cancer Research|July 10, 2025
AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal CancerDaniela Conticelli, Marco Volante, Filippo Pietrantonio, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOCEmilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
Cancers|December 17, 2024
Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival RiskAlessandro Gambella, Roberto Fiocca, Marialuisa Lugaresi, et al.
Biomedicines|September 27, 2025
TCF Plus Radiochemotherapy Versus Neoadjuvant Radiochemotherapy Versus Flot Perioperative Chemotherapy in Esophageal Adenocarcinoma: The Results of a Three-Cohort, Multi-Centric Comparison: The A4 StudyMarco Lorenzo Bonù, Giulia Volpi, Gloria Zanni, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Cancers|January 11, 2024
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric CancerMaria Bencivenga, Silvia Ministrini, Paolo Morgagni, et al.
Updates in Surgery|July 16, 2017
Complications after gastrectomy for cancer: Italian perspectiveGian Luca Baiocchi, Simone Giacopuzzi, Daniele Marrelli, et al.
Cancers|February 10, 2021
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective AnalysisStefano de Pascale, Paolo Parise, Michele Valmasoni, et al.
Cancers|October 23, 2021
The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction AdenocarcinomaRoberto Fiocca, Luca Mastracci, Marialuisa Lugaresi, et al.
Frontiers in Oncology|April 4, 2022
The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon's Conduct During the Surgical Treatment of Advanced Gastric Cancer-Study Protocol for an International Multicenter Prospective StudyPietro Maria Lombardi, Michele Mazzola, Vincenzo Nicastro, et al.
Cancer Research|July 10, 2025
AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal CancerDaniela Conticelli, Marco Volante, Filippo Pietrantonio, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOCEmilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
Cancers|December 17, 2024
Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival RiskAlessandro Gambella, Roberto Fiocca, Marialuisa Lugaresi, et al.
Biomedicines|September 27, 2025
TCF Plus Radiochemotherapy Versus Neoadjuvant Radiochemotherapy Versus Flot Perioperative Chemotherapy in Esophageal Adenocarcinoma: The Results of a Three-Cohort, Multi-Centric Comparison: The A4 StudyMarco Lorenzo Bonù, Giulia Volpi, Gloria Zanni, et al.
Pageof 13